Glomerular endothelial cytotoxity and dysfunction in nephrosis with focal segmental glomerulosclerosis

被引:0
作者
Futrakul, N [1 ]
Siriviriyakul, P
Panichakul, T
Butthep, P
Patumraj, S
Futrakul, P
机构
[1] King Chulalongkorn Mem Hosp, Dept Physiol, Bangkok, Thailand
[2] King Chulalongkorn Mem Hosp, Dept Pediat, Bangkok, Thailand
[3] Chulabhorn Res Inst, Dept Immunol, Bangkok, Thailand
[4] Ramathibodi Hosp, Dept Immunocytol, Bangkok, Thailand
关键词
glomerular endothelial dysfunction; cytokine; endothelial cell cytotoxicity; nephrosis; focal segmental glomerulosclerosis;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Glomerular endothelial cell dysfunction (GED) with defective release of vasodilator has been delineated in nephrosis (NS) in vivo and in vitro studies. In NS with focal segmental glomerulosclerosis (FSGS), an immunocirculatory balance may be impaired due to defective anti-inflammatory cytokine. This study aimed at simultaneous determination of both proinflammatory cytokine (tumor necrosis factor alpha) and an anti-inflammatory cytokine (interleukin-10) in NS with FSGS. An endothelial cell cytotoxicity (ECC) was also examined using nephrotic serum. It was shown that (1) the initial endothelial cell cytotoxicity was significantly different from the control, (2) ratio between tumor necrosis alpha and interleukin-10 was significantly elevated, and (3) intrarenal hemodynamics was changed significantly.
引用
收藏
页码:469 / 473
页数:5
相关论文
共 17 条
[11]   T-lymphocyte populations and cytokines in childhood nephrotic syndrome [J].
Lama, G ;
Luongo, I ;
Tirino, G ;
Borriello, A ;
Carangio, C ;
Salsano, ME .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 39 (05) :958-965
[12]   Interleukin-18 and interleukin-12 synergize to stimulate the production of vascular permeability factor by T lymphocytes in normal subjects and in patients with minimal-change nephrotic syndrome [J].
Matsumoto, K ;
Kanmatsuse, K .
NEPHRON, 2000, 85 (02) :127-133
[13]   Augmented interleukin-18 production by peripheral blood monocytes in patients with minimal-change nephrotic syndrome [J].
Matsumoto, K ;
Kanmatsuse, K .
AMERICAN JOURNAL OF NEPHROLOGY, 2001, 21 (01) :20-27
[14]  
NAGASE M, 1981, 8 INT C NEPHR, P239
[15]  
SAYENA S, 1993, NEPHRON, V65, P56
[16]  
SHALHOUB RJ, 1974, LANCET, V2, P556
[17]   Antitumor activity of triptolide against cholangiocarcinoma growth in vitro and in hamsters [J].
Tengchaisri, T ;
Chawengkirttikul, R ;
Rachaphaew, N ;
Reutrakul, V ;
Sangsuwan, R ;
Sirisinha, S .
CANCER LETTERS, 1998, 133 (02) :169-175